In 2023, the mortality rate from genitourinary system diseases in Canada stood at 15.7 male deaths per 100,000 men. Based on the forecast data from 2024 to 2028, there is a projected gradual increase from 15.9 to 16.5. The average year-on-year increase over the past two years is approximately 1.3%, while the CAGR over the forecast period is around 1%. These figures suggest a steady upward trend in mortality rates.
Future trends to watch for include potential advancements in medical treatments and preventive healthcare, demographic shifts, and healthcare policy changes, which could influence these mortality rates positively or negatively. Monitoring technological and medical breakthroughs will be crucial in addressing these health challenges.
